Search results
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 14 hours agoNovavax (NASDAQ: NVAX) stock is suddenly a buy again this year, with its stock price more than tripling since the ...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 1 day agoShares now have a top Relative Strength Rating of 99. The RS Rating pits all stocks, regardless of...
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks via Yahoo Finance· 4 days agoZacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing...
Novavax, Inc. (NASDAQ:NVAX) has caught the attention of institutional investors who hold a sizeable...
Simply Wall St. via Yahoo Finance· 4 days ago(NASDAQ:NVAX) should be aware of the most powerful shareholder groups. We can see that...
Novavax (NASDAQ:NVAX) Shares Gap Down to $19.56
ETF DAILY NEWS· 6 days agoShares of Novavax, Inc. (NASDAQ:NVAX – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $19.56, but ...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 5 hours agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
...Last Week (June 1-June 7): Are These In Your Portfolio? - Agios Pharmaceuticals (NASDAQ:AGIO),...
Benzinga· 5 days agoMid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX,...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 4 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 3 days agoThe transactions, which took place on June 11, 2024, resulted in the sale of Moderna stock worth...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 3 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
